AbbVie’s Produodopa approved by SMC to treat Parkinson’s disease patients in Scotland
The progressive neurological disorder affects approximately 12,400 people in Scotland
Read More
Tag: Produodopa
- Liverpool and McMaster University announce £300,000 strategic research partnership
- Study finds link between malaria parasites developing antimalarial drug resistance
- Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients
- Closed Loop and Pharmanovia investigate precision medicine combination in hypertension
- US study reveals interferon combinations cause lupus symptoms and affect treatment
